The objective of the EFSD/Lilly Young Investigator Research Awards is to encourage innovative research in the fields of diabetes and its complications, and to promote excellence in medical education. Applicants should have demonstrated their ability in the field of diabetes research.
Research Awards will be made in the sum of Euro 50,000 (fifty thousand) each.
Award Application
Applications can be submitted by early career scientists: scientists and clinicians at an early stage of their career, up to 7 years since completion of their most recent degree (PhD, MSc, or MD degrees). Eligibility can be extended for reasons such as maternity, paternity, illness, national service, clinical training, natural disasters, or asylum, if clearly described (further documentation may be requested at the discretion of EASD/EFSD). The time since the last degree may not exceed seven years before 1 January in the year the Fellowship is awarded. Fellows may not hold a permanent appointment.
Applicants to all EFSD programmes are encouraged to become paid-up members of EASD. Details on how to become a member can be found on the EASD website or contact membership@easd.org for further information.
Research Awards must be held at a non-profit institution based in Europe or an associated country (for detailed country list, please see here).
Application forms may be downloaded here:
All applications must be prepared on the official forms and completed in strict accordance with the detailed instructions to be found on these forms. Applications which do not comply with the instructions given in the application form will not be considered for review.
Please send your application as one complete PDF email attachment to foundation@easd.org by 12:00 midday (CET) on the deadline date 17 February 2025.
Completed applications will be evaluated by an independent scientific committee.
Upon completion of the Awards, the recipient may be invited to present his/her research results at a scientific meeting hosted by Lilly.
Reporting Requirements and Approval of Funding
All funded applications will receive initial funding instalment upon confirmation of the approval of the Review Committee as appropriate. 90% of the funding will be provided at the start of the programme while the remaining 10% will be paid upon submission of final scientific and financial report. All reports will be subject to assessment prior to the release of any further funds.
Investigators must provide EFSD with copies of papers accepted for publication, and must acknowledge the support of the Programme in all written material by use of the phrase: "Supported by EFSD/Lilly".
Schedule
Announcement: September 2024
Application Deadline: 17 February 2025
Anticipated Award: May 2025
Enquiries
Enquiries should be directed to foundation@easd.org.
Applications can be submitted by early career scientists: scientists and clinicians at an early stage of their career, up to 7 years since completion of their most recent degree (PhD, MSc, or MD degrees). Eligibility can be extended for reasons such as maternity, paternity, illness, national service, clinical training, natural disasters, or asylum, if clearly described (further documentation may be requested at the discretion of EASD/EFSD). The time since the last degree may not exceed seven years before 1 January in the year the Fellowship is awarded. Fellows may not hold a permanent appointment.
Applicants to all EFSD programmes are encouraged to become paid-up members of EASD. Details on how to become a member can be found on the EASD website or contact membership@easd.org for further information.
Research Awards must be held at a non-profit institution based in Europe or an associated country (for detailed country list, please see here).
Sponsor Institute/Organizations: European Foundation for the Study of Diabetes (EFSD)
Address: Rheindorfer Weg 3 40591 Düsseldorf Germany Phone: +49 211 758 469 0 Email: foundation@easd.org Website: https://www.europeandiabetesfoundation.org
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Feb 17, 2025
$54,433
Affiliation: European Foundation for the Study of Diabetes (EFSD)
Address: Rheindorfer Weg 3 40591 Düsseldorf Germany Phone: +49 211 758 469 0 Email: foundation@easd.org Website: https://www.europeandiabetesfoundation.org
Website URL: https://www.europeandiabetesfoundation.org/workshops/93-efsdlilly-young-investigator-research-award-programme.html
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.